Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fleischer

Showing results (171-180 of 257) with videos related to

Pageof 26
Sort By:
Allergy and Asthma Proceedings|June 11, 2020
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergyDavid M Fleischer, Jonathan M Spergel, Edwin H Kim, et al.
The World Allergy Organization Journal|March 26, 2021
Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitisCarina Venter, Michaela P Palumbo, Katherine A Sauder, et al.
Allergy|September 7, 2021
Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapyPhilippe Bégin, John Andrew Bird, Jonathan M Spergel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 2018
The importance of reducing risk in peanut allergy: Current and future therapiesWayne G Shreffler, Joe L Baumert, Benjamin C Remington, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 18, 2018
Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensusYvan Vandenplas, Amir Hamzah Abdul Latiff, David M Fleischer, et al.
Pharmaceutics|June 27, 2024
Development of <i>neffy</i>, an Epinephrine Nasal Spray, for Severe Allergic ReactionsAnne K Ellis, Thomas B Casale, Michael Kaliner, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 20, 2024
Bidirectional associations between IgE-mediated food allergy and atopic dermatitisC Venter, K Pickett-Nairne, D H Glueck, et al.
The Journal of Allergy and Clinical Immunology. Global|June 11, 2025
Health care resource utilization of patients with asthma and food allergy initiating omalizumabJohn A Bird, Aimee M Near, Julie Wang, et al.
Allergy|April 25, 2022
Psychometric parameters of food allergy quality of life during an allergen immunotherapy trialGabriel Lins de Holanda Coelho, Audrey DunnGalvin, Matthew Greenhawt, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2016
Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patchStacie M Jones, Wence K Agbotounou, David M Fleischer, et al.
Pageof 26

Showing results (171-180 of 257) with videos related to

Sort By:
Pageof 26
Allergy and Asthma Proceedings|June 11, 2020
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergyDavid M Fleischer, Jonathan M Spergel, Edwin H Kim, et al.
The World Allergy Organization Journal|March 26, 2021
Incidence and timing of offspring asthma, wheeze, allergic rhinitis, atopic dermatitis, and food allergy and association with maternal history of asthma and allergic rhinitisCarina Venter, Michaela P Palumbo, Katherine A Sauder, et al.
Allergy|September 7, 2021
Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapyPhilippe Bégin, John Andrew Bird, Jonathan M Spergel, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 1, 2018
The importance of reducing risk in peanut allergy: Current and future therapiesWayne G Shreffler, Joe L Baumert, Benjamin C Remington, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|September 18, 2018
Partially hydrolyzed formula in non-exclusively breastfed infants: A systematic review and expert consensusYvan Vandenplas, Amir Hamzah Abdul Latiff, David M Fleischer, et al.
Pharmaceutics|June 27, 2024
Development of <i>neffy</i>, an Epinephrine Nasal Spray, for Severe Allergic ReactionsAnne K Ellis, Thomas B Casale, Michael Kaliner, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 20, 2024
Bidirectional associations between IgE-mediated food allergy and atopic dermatitisC Venter, K Pickett-Nairne, D H Glueck, et al.
The Journal of Allergy and Clinical Immunology. Global|June 11, 2025
Health care resource utilization of patients with asthma and food allergy initiating omalizumabJohn A Bird, Aimee M Near, Julie Wang, et al.
Allergy|April 25, 2022
Psychometric parameters of food allergy quality of life during an allergen immunotherapy trialGabriel Lins de Holanda Coelho, Audrey DunnGalvin, Matthew Greenhawt, et al.
The Journal of Allergy and Clinical Immunology|February 28, 2016
Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patchStacie M Jones, Wence K Agbotounou, David M Fleischer, et al.
Pageof 26